By Nigam Arora & Dr. Natasha Arora
Signal(s) to enter, add, reduce, exit, hold or change.
659% Gain
Nvidia (NVDA) fell into the buy zone about 17 months ago and is long from $125.51. It is trading at $952.74 in pre-market as of this writing. This represents a gain of 659% in about 17 months.
There have been other opportunities to buy NVDA and in the future there will continue to be more opportunities to buy NVDA for those who are not in the stock.
Buy Zone
For those who are following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial).
For those following the Best Way, the new buy zone is ***.
Earnings Power
We previously wrote in the Morning Capsule on February 22, 2024:
In The Arora Report analysis, if the competition does not heat up, NVDA is on track to achieve $45 – $50 in earnings in 2027. If this comes true, on this basis, NVDA is the cheapest tech stock. Of course the reality is that competition will heat up. Nonetheless, investors need to be aware that based on the current trajectory, NVDA is not an expensive stock.
New Target
Assuming competition does not develop and hyper scalers continue to buy at the present rate, NVDA stock can easily go to ***. However in reality, competition will develop. For the time being, the target is being raised ***.
Time To Protect
Technically NVDA is very overbought and can easily pullback. For this reason, it is time to protect profits. The best way to protect profits is to hedge partial quantity.
For those who want to learn to hedge, the Hedge The Risk Seminar is available.
Those who do not know how to hedge and also do not want to learn how to hedge may consider taking partial profits while still retaining most of the position.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
